Cosmo Pharmaceuticals N.V.

BATS-CHIXE:COPNZ Stock Report

Market Cap: CHF 1.0b

Cosmo Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of COPNZ?
Owner TypeNumber of SharesOwnership Percentage
Institutions2,486,60915.5%
General Public5,928,93236.9%
Private Companies7,630,34547.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 62.71% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
38.3%
Cassiopea SA
6,137,252CHF 394.0m0%no data
9.31%
Heinrich Herz AG
1,493,093CHF 95.9m0%no data
4.15%
dievini Hopp BioTech holding GmbH & Co. KG
666,062CHF 42.8m0%10.44%
3.41%
UBS Asset Management AG
546,543CHF 35.1m-0.44%no data
2.22%
The Vanguard Group, Inc.
356,799CHF 22.9m-0.02%no data
0.93%
BlackRock, Inc.
148,800CHF 9.6m2.38%no data
0.69%
Baillie Gifford & Co.
111,135CHF 7.1m0%no data
0.61%
Dimensional Fund Advisors LP
97,735CHF 6.3m7.44%no data
0.41%
JP Morgan Asset Management
66,588CHF 4.3m0%no data
0.39%
Norges Bank Investment Management
63,151CHF 4.1m0%no data
0.37%
ZKB Asset Management
59,370CHF 3.8m0.03%0.01%
0.28%
Zürcher Kantonalbank, Investment Arm
45,229CHF 2.9m-13.9%0.03%
0.26%
3V Asset Management AG
41,656CHF 2.7m0%1.85%
0.24%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
39,032CHF 2.5m77.8%no data
0.2%
Deka Investment GmbH
31,650CHF 2.0m0%no data
0.19%
Pictet Asset Management SA
29,713CHF 1.9m0%no data
0.18%
Fidelity International Ltd
29,426CHF 1.9m0%no data
0.11%
Charles Schwab Investment Management, Inc.
17,644CHF 1.1m0%no data
0.091%
State Street Global Advisors, Inc.
14,605CHF 937.6k5.79%no data
0.08%
ODDO BHF Asset Management SAS
12,840CHF 824.3k0%0.01%
0.077%
Deutsche Asset & Wealth Management
12,433CHF 798.2k0%no data
0.075%
Valiant Bank AG, Asset Management Arm
12,050CHF 773.6k0%0.08%
0.072%
Principal Vermoegensverwaltung AG
11,500CHF 738.3k0%0.89%
0.061%
Rieter Fischer Partners
9,780CHF 627.9k0%0.38%
0.049%
PMG Investment Solutions AG
7,920CHF 508.5k0%0.17%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 12:31
End of Day Share Price 2025/01/03 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cosmo Pharmaceuticals N.V. is covered by 14 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Laura Pfeifer-RossiBank am Bellevue
Silvia SchanzBank Vontobel AG
Laura HindleyBerenberg